Guenka Petrova

Citado por

	Total	Desde 2019
Citas	3132	2306
Índice h	29	25
Índice i10	67	48

520

260

130

390

200920102011201220132014201520162017201820192020202120222023202417 11 23 27 32 67 90 109 166 200 317 470 520 481 415 101

Acceso público

Ver todo

15 artículos

0 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Maria DimitrovaMedical University of Sofia, Faculty of PharmacyDirección de correo verificada de pharmfac.net
Prof. László Gulácsi, DScBudapest, Hungary, Óbuda UniversityDirección de correo verificada de uni-obuda.hu
Zoltán KalóCenter for Health Technology Assessment, Semmelweis University; Syreon ResDirección de correo verificada de semmelweis-univ.hu
Brodszky ValentinCorvinus University of BudapestDirección de correo verificada de uni-corvinus.hu
Dominik GolickiDepartment of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, PolandDirección de correo verificada de wum.edu.pl
Baji PetraCorvinus University of Budapest; University of BristolDirección de correo verificada de uni-corvinus.hu
Bistra AngelovskaProfessor, Goce Delcev University of Shtip, MacedoniaDirección de correo verificada de ugd.edu.mk
Andras Inotai PharmD PhDCenter for Health Technology Assessment Semmelweis UniversityDirección de correo verificada de semmelweis-univ.hu
Olga LöblováDepartment of Sociology, University of CambridgeDirección de correo verificada de cam.ac.uk
Milen DimitrovMedical University of SofiaDirección de correo verificada de pharmfac.mu-sofia.bg
Imre BonczPécsi TudományegyetemDirección de correo verificada de etk.pte.hu
Saz-Peiro,PabloProfesor medicinaDirección de correo verificada de unizar.es
Hadjipanayis AdamosMedical School - European University CyprusDirección de correo verificada de euc.ac.cy
Jan StyczynskiCollegium Medicum Bydgoszcz, Nicolaus Copernicus University TorunDirección de correo verificada de cm.umk.pl
Aslak SteinsbekkProfessor Professor in Behavioural sciences in medicine and Health service research at NTNUDirección de correo verificada de ntnu.no
Søren VentegodtQuality of Life Research Center, CopenhagenDirección de correo verificada de livskvalitet.org
Галина ПетроваТомский государственный университетDirección de correo verificada de persona.tsu.ru
Albena ZlatarevaMedical University of VarnaDirección de correo verificada de mu-varna.bg

Seguir

Guenka Petrova

Prof. Pharmacoeconomic, Pharmaceutical Legislation, Medical University of Sofia, Faculty of Pharmacy

Dirección de correo verificada de pharmfac.net - Página principal

Pharmacoeconomics Pharmaceutical legilation Pharmacy Pharmaceuticals


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Policies for biosimilar uptake in Europe: an overview E Moorkens, AG Vulto, I Huys, P Dylst, B Godman, S Keuerleber, B Claus, ... PloS one 12 (12), e0190147, 2017	233	2017
Use of complementary and alternative medicine by children in Europe: published data and expert perspectives TJ Zuzak, J Boňková, D Careddu, M Garami, A Hadjipanayis, J Jazbec, ... Complementary therapies in medicine 21, S34-S47, 2013	184	2013
The implementation of managed entry agreements in Central and Eastern Europe: findings and implications A Ferrario, D Arāja, T Bochenek, T Čatić, D Dankó, M Dimitrova, J Fürst, ... Pharmacoeconomics 35, 1271-1285, 2017	161	2017
Barriers for access to new medicines: searching for the balance between rising costs and limited budgets B Godman, A Bucsics, P Vella Bonanno, W Oortwijn, CC Rothe, A Ferrario, ... Frontiers in Public Health 6, 328, 2018	152	2018
EQ-5D in central and Eastern Europe: 2000–2015 F Rencz, L Gulácsi, M Drummond, D Golicki, V Prevolnik Rupel, J Simon, ... Quality of Life Research 25, 2693-2710, 2016	137	2016
Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria L Gulácsi, AM Rotar, M Niewada, O Löblová, F Rencz, G Petrova, I Boncz, ... The European journal of health economics 15, 13-25, 2014	109	2014
Pricing and reimbursement of biosimilars in Central and Eastern European countries P Kawalec, E Stawowczyk, T Tesar, J Skoupa, A Turcu-Stiolica, ... Frontiers in pharmacology 8, 288, 2017	76	2017
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications B Godman, A Hill, S Simoens, G Selke, I Selke Krulichová, ... Expert review of pharmacoeconomics & outcomes research 21 (4), 527-540, 2021	64	2021
Use of biologics for psoriasis in Central and Eastern European countries F Rencz, L Kemény, JZ Gajdácsi, W Owczarek, P Arenberger, GS Tiplica, ... Journal of the European Academy of Dermatology and Venereology 29 (11), 2222 …, 2015	58	2015
Adaptive pathways: possible next steps for payers in preparation for their potential implementation P Vella Bonanno, M Ermisch, B Godman, AP Martin, J Van Den Bergh, ... Frontiers in pharmacology 8, 497, 2017	53	2017
Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income … B Godman, C Grobler, M Van-De-Lisle, J Wale, WB Barbosa, A Massele, ... Expert opinion on pharmacotherapy 20 (18), 2237-2255, 2019	50	2019
Pricing of oral generic cancer medicines in 25 European countries; findings and implications B Godman, A Hill, S Simoens, A Kurdi, J Gulbinovič, A Martin, A Timoney, ... Generics and Biosimilars Initiative Journal 8 (2), 49-70, 2019	50	2019
Assessment of the expectancy, seriousness and severity of adverse drug reactions reported for chronic obstructive pulmonary disease therapy G Petrova, A Stoimenova, M Dimitrova, M Kamusheva, D Petrova, ... SAGE open medicine 5, 2050312117690404, 2017	48	2017
Low fresh gas flow balanced anesthesia versus target controlled intravenous infusion anesthesia in laparoscopic cholecystectomy: a cost-minimization analysis PD Stevanovic, G Petrova, B Miljkovic, R Scepanovic, R Perunovic, ... Clinical therapeutics 30 (9), 1714-1725, 2008	45	2008
Life expectancy and survival analysis of patients with diabetes compared to the non diabetic population in Bulgaria K Tachkov, K Mitov, Y Koleva, Z Mitkova, M Kamusheva, M Dimitrova, ... PloS one 15 (5), e0232815, 2020	44	2020
Proposal for a regulation on health technology assessment in Europe–opinions of policy makers, payers and academics from the field of HTA P Vella Bonanno, A Bucsics, S Simoens, AP Martin, W Oortwijn, ... Expert review of pharmacoeconomics & outcomes research 19 (3), 251-261, 2019	44	2019
Pharmaceutical regulation in Central and Eastern European countries: a current review P Kawalec, T Tesar, L Vostalova, P Draganic, M Manova, A Savova, ... Frontiers in pharmacology 8, 892, 2017	43	2017
The European challenges of funding orphan medicinal products M Szegedi, T Zelei, F Arickx, A Bucsics, E Cohn-Zanchetta, J Fürst, ... Orphanet journal of rare diseases 13, 1-8, 2018	41	2018
Evaluation of consumer satisfaction using the tetra-class model F Clerfeuille, Y Poubanne, M Vakrilova, G Petrova Research in Social and Administrative Pharmacy 4 (3), 258-271, 2008	40	2008
Patient access, unmet medical need, expected benefits, and concerns related to the utilisation of biosimilars in Eastern European countries: a survey of experts A Inotai, M Csanadi, G Petrova, M Dimitrova, T Bochenek, T Tesar, K York, ... BioMed Research International 2018, 2018	39	2018

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores